To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis
NCT ID: NCT04566666
Last Updated: 2026-01-20
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
263 participants
INTERVENTIONAL
2021-03-25
2025-08-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis
NCT05896527
A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque Psoriasis
NCT04594928
Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis
NCT01206660
Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis
NCT00606450
Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis
NCT02933866
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo of SCD-044 product
Placebo of SCD-044 study drug
Placebo
Placebo of SCD-044 product
SCD-044 Tablets_Low Dose (Dose 1)
SCD-044 tablets at Low Dose (Dose 1)
SCD-044_Low Dose (Dose 1)
SCD-044 tablets in Low Dose (Dose 1)
SCD-044 Tablets_Intermediate Dose (Dose 2)
SCD-044 tablets at Intermediate Dose (Dose 2)
SCD-044_Intermediate Dose (Dose 2)
SCD-044 tablets in Intermediate Dose (Dose 2)
SCD-044 Tablets_High Dose (Dose 3)
SCD-044 tablets at High Dose (Dose 3)
SCD-044_High Dose (Dose 3)
SCD-044 in High Dose (Dose 3)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo
Placebo of SCD-044 product
SCD-044_Low Dose (Dose 1)
SCD-044 tablets in Low Dose (Dose 1)
SCD-044_Intermediate Dose (Dose 2)
SCD-044 tablets in Intermediate Dose (Dose 2)
SCD-044_High Dose (Dose 3)
SCD-044 in High Dose (Dose 3)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Aged at least 18 years.
3. Subjects with no history of active TB or symptoms of TB
Exclusion Criteria
2. Subjects who have anticipated the requirement of topical therapy, phototherapy, or systemic therapy for psoriasis during the trial.
3. Subjects with history or presence of uveitis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sun Pharmaceutical Industries Limited
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yuma Clinical Trials, LLC
Yuma, Arizona, United States
T. Joseph Raoof Md, Imc./Encino Research Center
Encino, California, United States
Metropolis Dermatology
Los Angeles, California, United States
Axis Clinical Trials
Los Angeles, California, United States
Velocity Clinical Research
North Hollywood, California, United States
Unison Clinical Trials
Sherman Oaks, California, United States
Clarity Dermatology
Castle Rock, Colorado, United States
Accel Research Sites Network - Annexus Dermatology & Aestheitcs
DeLand, Florida, United States
Palm Beach Dermatology Group
Delray Beach, Florida, United States
Revival Research Corporation
Doral, Florida, United States
FXM Clinical Research Fort Lauderdale
Fort Lauderdale, Florida, United States
Direct Helpers Research Center
Hialeah, Florida, United States
Evolution Clinical Trials, Inc
Hialeah Gardens, Florida, United States
JD Medical Group, LLC
Miami, Florida, United States
MedOne Clinical Research, LLC
Miami, Florida, United States
Century Research LLC
Miami, Florida, United States
FXM Clinical Research Miami
Miami, Florida, United States
FXM Clinical Research Miramar
Miramar, Florida, United States
Adtremed Inc
Tampa, Florida, United States
Advanced Clinical Research Institute
Tampa, Florida, United States
Alliance Clinical Research of Tampa
Tampa, Florida, United States
Oracle Clinical Research
College Park, Georgia, United States
Physicians Research Group
West Lafayette, Indiana, United States
Revival research Institute, LLC
Troy, Michigan, United States
DFW Clinical Research, LLC
Dallas, Texas, United States
SMS Clinical Research
Mesquite, Texas, United States
Stride Clinical Research
Sugar Land, Texas, United States
Springville Dermatology/ CCT Research
Springville, Utah, United States
Skin DC Derm
Arlington, Virginia, United States
Clinica de Dermatologia y Cirugia de Piel
La Libertad, , El Salvador
Clinica Dermatologica
San Salvador, , El Salvador
Clinica Vargas
San Salvador, , El Salvador
North Estonia Medical Centre Foundation Ltd.
Tallinn, , Estonia
Clinical Research Centre OU
Tartu, , Estonia
Malkhaz Katsiashvili Multiprofile Emergency Medicine Center LLC
Tbilisi, , Georgia
Israeli - Georgian Medical Research Clinic Helsikor LLC
Tbilisi, , Georgia
Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic LLC
Tbilisi, , Georgia
Emergency Cardiology Center by Academician G. Chapidze LLC
Tbilisi, , Georgia
LTD Aversi Clinic
Tbilisi, , Georgia
TIM - Tbilisi Institute of Medicine LLC
Tbilisi, , Georgia
David Abuladze Georgian-Italian Clinic LLC
Tbilisi, , Georgia
ClinicMed
Bialystok, , Poland
Synexus Polska Sp. z o.o. Branch in Gdansk
Gdansk, , Poland
Dobry Lekarz' Modern Therapies Center Limited Liability Company
Krakow, , Poland
Landa Specialist Doctor's Offices
Krakow, , Poland
GLOBE Clinical Research
Kłodzko, , Poland
Appletreeclinics Clinical Research Centre
Lodz, , Poland
EMC Medical Institute Joint Stock Company, "Certus" Private Healthcare Facility Hospital No. 1
Poznan, , Poland
TWOJA PRZYCHODNIA Medical Centre of Szczecin, Twoja Przychodnia SCM
Szczecin, , Poland
National Medical Institute of the MSWiA, Clinical Department of Dermatology
Warsaw, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SCD-044-19-14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.